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In July 2007, a cluster of meningitis cases caused by an 
echovirus 4 strain was detected in 1 indigenous community 
in the Top End of the Northern Territory of Australia. Illness 
was characterized by fever, vomiting, and headache. Over 
the next 4 months, additional cases of meningitis and the 
fever and vomiting syndrome emerged in other indigenous 
communities and subsequently in the major urban center 
of Darwin. We describe the epidemiology of 95 laboratory-
confi rmed meningitis cases and conclude that the epidemic 
fever and vomiting syndrome was caused by the same 
enterovirus. Nucleotide sequencing of the whole genome 
verifi ed this enterovirus (AUS250G) as a strain of echovirus 
type 4. Viral protein 1 nucleotide sequencing demonstrated 
96% homology with an echovirus 4 strain responsible for 
a large outbreak of meningitis in the Yanbian Prefecture of 
China in 1996. 
Enteroviruses are among the most common human viral pathogens. Recent reports from the United States have 
documented >50 serotypes of enterovirus causing illness in 
humans (1). Illness syndromes with established causal links 
to enteroviruses include acute hemorrhagic conjunctivitis; 
viral meningitis; hand, foot, and mouth disease; and acute 
ascending paralysis (including poliomyelitis). In July 2007, 
a disease control unit in the Northern Territory of Austra-
lia reported a cluster of viral meningitis cases in a nearby 
community. Nucleic acid testing of the cerebrospinal fl uid 
(CSF) of these patients detected an enterovirus.
The Northern Territory of Australia has a population 
of 210,000 living in an area of 1.35 million km2; the climate 
varies from desert and semiarid in the south to subtropi-
cal in the north. The northern part, known as the Top End, 
is characterized by several small urban centers and many 
small scattered indigenous communities with populations 
of 300–2,000. Darwin (population 100,000) is the major 
urban center. Approximately 30% of the population of the 
Northern Territory consists of indigenous Australians.
This cluster of meningitis cases coincided with an out-
break of another viral illness in the same and nearby com-
munities; the illness affected mainly children and was char-
acterized by fever, vomiting, and headache. During the next 
4 months this epidemic febrile vomiting syndrome (EFVS) 
was reported in multiple communities in the northern part 
of the Northern Territory and eventually in Darwin. During 
the same period, clusters of viral meningitis were also be-
ing reported in some of the communities experiencing the 
EFVS.
We hypothesize that the cluster of viral meningitis 
cases and the EFVS were different manifestations of the 
same infection, caused by a strain of echovirus type 4 (E4) 
virus. This enterovirus was closely related to 2 E4 strains 
that caused a large outbreak of viral meningitis in the Yan-
bian prefecture of China in 1996 (2); ≈5,000 cases from a 
population of 2.16 million were identifi ed.
Methods
Patients
A case of acute E4 enteroviral illness was defi ned as 
the detection, in 2007 in a resident of the Northern Terri-
tory, either of E4 in a CSF specimen or E4 in samples from 
another site during an illness characterized by fever and 
severe headache. Infants were children aged <1 year; chil-
dren (including infants), <15 years of age; and adults, >15 
years. Cases were included in our study only if specimens 
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were collected in 2007 and samples from patients had a 
positive PCR or culture for E4 at the reference laboratory. 
A questionnaire was developed and details of cases were 
collected by a review of hospital case notes and, where 
possible, by telephone interviews with case-patients. The 
questionnaire documented clinical symptoms and signs 
together with laboratory results and risk factors, such as 
potential occupational exposure, child care, institutional 
exposure, or illness in the immediate family. Duration of 
illness was identifi ed by discussion with the case-patient 
or, if the case-patient could not be contacted, was defi ned 
as the difference between date of symptom onset according 
to the medical record and date of hospital discharge.
The spread of the EFVS was investigated by asking 
senior clinic staff at all the remote community health cen-
ters in the regions affected about the local presence of a 
recent epidemic of fever, vomiting, and headache. If staff 
recalled such an epidemic, details were recorded about its 
timing, number of case-patients seen in the community 
health center, and the proportion of case-patients who 
were children. These interviews were all conducted within 
2 months after the outbreak. Attack rates were calculated 
by using these estimates and the population of each com-
munity according to 2006 census data from the Australian 
Bureau of Statistics (3).
We collated data in Microsoft Excel 2000 (Redmond, 
WA, USA) and performed statistical analysis using STA-
TA version 9.0 (StataCorp LP, College Park, TX, USA). 
Logistic regression was used to examine the relationship 
between the outcome variables (duration of illness, hos-
pital admission, and length of stay) with the independent 
variables discussed below. Multivariate logistic regression 
models were built using a backwards stepwise approach. 
We compared categorical variables using the χ2 test and 
continuous variables using the Wilcoxon rank-sum test. A 
p value <0.05 was considered signifi cant.
Virus Isolation, Detection, and Identifi cation
Feces samples were cultured for enterovirus by using 
a human diploid fi broblast cell line. Enterovirus molecular 
testing was performed directly on CSF samples, dry throat 
swabs, feces samples, and fecal cell culture supernatants 
that demonstrated a typical cytopathic effect. In-house 
seminested reverse transcription–PCR (RT-PCR) was used, 
which was specifi c for 2 regions of the 5′ untranslated re-
gion (UTR) of the enterovirus genome (4,5). This 2-region 
RT-PCR method detects a wide range of enteroviruses. 
CSF samples were also routinely tested for bacterial patho-
gens by culture and for herpes simplex virus by PCR.
Enterovirus genotyping was performed by direct se-
quencing of the viral protein (VP) 1 capsid coding gene. 
Total RNA was extracted from cell culture supernatant 
followed by RT-PCR amplifi cation by using primers pre-
viously described (6). The products were sequenced on 
both strands by using the ABI Prism BigDye Terminator 
v3.1 system (Applied Biosystems, Foster City, CA, USA) 
according to the manufacturer’s instructions. Sequencing 
reactions were interrogated on an ABI Prism 3130XL 16-
channel Genetic Analyzer (Applied Biosystems). The de-
duced sequence was compared for identifi cation by align-
ment with enterovirus sequences available in GenBank by 
using BLASTn (http://blast.ncbi.nlm.nih.gov). The whole 
viral genome was sequenced by use of primers designed 
from the obtained sequences and from aligned GenBank 
E4 sequences. We performed phylogenetic analysis for 
the VP1 gene using MEGA version 3.0 software (www.
megasoftware.net) by the neighbor-joining method 
with the Kimura 2-parameter model and 1,000 bootstrap 
replicates.
Results
We identifi ed 95 cases of acute E4 viral illness. Seven-
ty-six of these cases had a positive PCR CSF result; 8 also 
had virus detected in throat or feces samples. In the remain-
ing 19, E4 was detected by PCR from a throat swab, a fecal 
specimen, or both. Records were reviewed on all cases, and 
interviews were conducted with 48 case-patients or a par-
ent if the case-patient was a child. Interviews were not pos-
sible for most indigenous case-patients who lived in remote 
communities because of a lack of home telephones.
Approximately equal numbers of male and female pa-
tients were affected (Table 1); most affected children were 
male (M:F ratio 1.4), and most affected adults were female 
(M:F ratio 0.8). Forty-six percent of case-patients were in-
digenous Australians. From the beginning of July through 
the fi rst week of October, most cases occurred in indigenous 
infants from remote communities in the Top End; from Oc-
tober through December, most were nonindigenous adults 
from urban Darwin and nearby communities (Figure 1). 
The pooled incidence in the 3 main affected regions was 
59.1/100,000. Ages of case-patients ranged from 3 days to 
56 years (median 12 years), with indigenous case-patients 
being signifi cantly younger (p<0.0001). Twenty-eight 
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Table 1. Incidence of meningitis caused by echovirus type 4 
virus, by age group and sex, Northern Territory, Australia, 2007 
Case-patient sex Case-patient
age group, y M F
Total no. 
case-patients Incidence* 
<1 16 12 28 1,025.0
1–4 3 3 6 54.9
5–14 11 7 18 71.4
15–24 12 11 23 94.0
25–34 3 10 13 47.3
35–44 2 1 3 11.4
45–64 2 2 4 11.3
>65 0 0 0 0.0
Total 49 46 95 59.1
*Per 100,000 population. 
Meningitis Caused by Echovirus Type 4
(30%) case-patients were <1 year of age, and 43 (45%) were 
>15 years of age. Incidence was highest in infants <1 year of 
age, followed by persons 15–24 years of age.
For adults, the most common symptom at onset was 
headache (70%); for infants and children, it was fever 
(48%). Common symptoms varied by age group (Table 
2). For infants, symptoms were invariably fever and ir-
ritability, although for several, poor peripheral perfusion 
was noted and neonatal bacterial sepsis was clinically 
suspected. Children and infants were signifi cantly more 
likely than adults to have fever (p = 0.001); infants were 
less likely than older children and adults to have vomiting 
(p<0.0001).
Duration of illness ranged from 3 to 28 days (me-
dian 7 days); length of hospital stay ranged from 0 to 10 
days (median 3 days). Sequelae, reported for only 4 case-
patients, included persistent headache and lethargy up to 
4 weeks post onset, but all were mild. Recent similar but 
milder symptoms, such as fever and headache, were re-
ported for immediate family members in 33 (56%) of 59 
case-patients from whom information was available. We 
did not seek clinical details and investigations of these 
family members.
Lumbar puncture was performed on 82 case-patients. 
Fifty-nine (72%) CSF samples showed an increased leu-
kocyte count, 45 (76%) of which had a predominance of 
mononuclear cells (55% of all samples). Of the 27 infants 
who had a lumbar puncture, 19 had normal microscopy 
without pleocytosis, despite all but 1 having the virus de-
tected in the CSF. Initial peripheral leukocyte differential, 
available for 90 case-patients, was normal for 30 (33%); 
50 (55%) had lymphopenia, 21 (23%) had neutrophilia, 2 
(2%) had lymphocytosis, and 1 (1%) had neutropenia.
Multivariate analysis showed that of all the potential 
markers of severity (age, sex, indigenous status, high CSF 
protein, CSF pleocytosis, lymphopenia, and neutrophilia) 
only age was associated with admission to hospital and 
length of stay. The odds ratio of children being admitted 
to hospital compared with adults was 14.8 (95% confi -
dence interval [CI] 3.2–69.3, p<0.001). When adjusted for 
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Figure 1. Indigenous and nonindigenous 
cases of echovirus type 4 virus illness, 
by week of onset, Northern Territory, 
Australia, 2007.
Table 2. Prevalence of clinical features and CSF abnormalities in persons affected by echovirus type 4 viral illness, by age group, 
Northern Territory, Australia, 2007* 
No. (%) case-patients by age group, y 
Features <1 1–4 5–14 >15
Total no. (%) 
case-patients
Clinical features n = 28 n = 6 n = 18 n = 43 N = 95 
 Fever 28 (100) 6 (100) 17 (94) 32 (74) 83 (87) 
 Headache 0 (0) 4 (67) 17 (94) 43 (100) 64 (67) 
 Vomiting 5 (18) 6 (100) 17 (94) 35 (81) 63 (66) 
 Photophobia† 1 (4) 2 (40) 7 (39) 34 (79) 44 (47) 
 Diarrhea 16 (57) 0 2 (12) 18 (42) 36 (39) 
 Neck stiffness 0 1 (17) 9 (50) 21 (51) 31 (33) 
 Confusion/irritability 16 (57) 2 (33) 2 (11) 7 (17) 27 (29) 
 Rash 6 (22) 2 (33) 3 (19) 5 (12) 16 (17) 
CSF abnormalities n = 27 n = 5 n = 15 n = 35 n = 82 
 Glucose <2.7 mmol/L 7 (27) 0 0 3 (9) 10 (12) 
 Increased CSF protein‡ 10 (39) 1 (20) 1 (7) 26 (74) 38 (47) 
 Leukocyte count >5 cells/mL 8 (30) 5 (100) 15 (100) 31 (90) 59 (72) 
 Leukocyte count >5 cells/mL and >50% monocytes 5 (19) 2 (40) 10 (67) 28 (80) 45 (55) 
*CSF, cerebrospinal fluid. 
†Presence or absence of clinical features was not discernible in all cases. 
‡Age-specific normal values for protein were defined as follows: <1 month, <0.9 mg/L; 1–2 months, <0.77 mg/L; 3 months, 0.6 mg/L; and >3 months, 0.45 
/L (7)
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indigenous status and sex the odds ratio was 13.0 (95% CI 
2.4–69.5, p = 0.003).  
The EFVS affected 26 of the 28 communities contact-
ed, and the median attack rate for children was 22% (range 
2%–57%); the overall attack rate was 18.6%. Twenty-six 
cases of viral meningitis occurred in remote indigenous 
communities in the same area; 19 of these occurred within 
3 weeks after the reported onset of the EFVS in their re-
spective communities. Cases of proven viral meningitis 
in children from remote communities represented 2.0% of 
the estimated number of EFVS cases in children; however, 
>50% of these cases came from just 2 communities.
The epidemic began in the east of the northern part of 
the Northern Territory and progressed to the west over the 
next 6 months (Figure 2). Nevertheless, the earliest case 
of E4 meningitis was in April in a Darwin adult, who also 
reported similar illness in fellow workers.
Not all E4 case-patients exhibited the clinical features 
of meningitis. For example, 3 adults had neither meningeal 
symptoms nor CSF pleocytosis, but nevertheless had E4 
detected in the CSF or feces. This fi nding suggests a spec-
trum of illness typical of enteroviruses, ranging from mild 
illness to meningitis, and supports the hypothesis that the 
EVFS was caused by the same virus.
Molecular Epidemiology
Product from the 5′ UTR PCRs was sequenced from 
all positive samples and by BLASTn search of the Gen-
Bank database; all had the closest homology to the Yan-
bian strains of echovirus type 4 (AF230973, AF233852). 
In addition, VP1 capsid coding gene sequences were ob-
tained from 9 of the isolates, and all closely matched the 
AUS250G strain.
A GenBank BLASTn search showed that the whole ge-
nome nucleotide sequence of the E4 strain (AUS250G) had 
84% homology with the Yanbian strains, and 81% homol-
ogy with E4 Pesacek (AY302557), a strain isolated in the 
United States in 1951 (8). The AUS250G strain also had a 
96% aa homology with the Pesacek strain, which is the only 
other complete E4 sequence in GenBank. Whole genome 
amino acid comparisons were not made with the Yanbian 
strains because amino acid translations of the Yanbian se-
quences were faulty, presumably due to nucleotide sequence 
errors. A phylogenetic tree of the complete VP1 nucleotide 
sequences (Figure 3) shows the relationship of AUS250G to 
other E4 strains, with the closest matches being a strain iso-
lated in Shiga, Japan (AB166855) and the 2 Yanbian strains. 
The entire AUS250G genome sequence has been deposited 
in GenBank under accession no. FJ172447.
Discussion
This cluster of viral meningitis cases was discovered 
quickly and was able to be accurately mapped and de-
scribed because of use of PCR testing of CSF samples. The 
overlapping symptomatology of both E4 meningitis and 
EFVS, together with the coincidence of cases of the former 
with outbreaks of the latter in remote communities and the 
high incidence of a similar illness in the relatives of menin-
gitis cases, led us to conclude that the EFVS was a milder 
form of infection with the same virus. Furthermore, E4 was 
detected in specimens from several patients with fever and 
vomiting but with no clinical diagnosis of meningitis. The 
infection appears to have had a high attack rate, particu-
larly in children in remote communities, and ≈2% of case-
patients either developed meningitis or were systemically 
sick enough to be admitted to hospital.
Our estimate of the attack rate must be viewed with 
caution because we relied on clinic staff estimates of case 
numbers some weeks after the epidemic rather than through 
contemporaneous records. Given the time and resource con-
straints on staff in the remote setting, case numbers could 
have been overstated. Nevertheless, the EFVS and the high 
rates of viral meningitis in the community unquestionably 
stressed the healthcare system, particularly in remote com-
munities. In addition, some schools in urban areas reported 
several cases of meningitis and absenteeism caused by viral 
illness in both staff and students, which led to anxiety in the 
school community. The news media was also interested and 
published reports of a “brain virus” infecting large numbers 
of people on the front page of the local newspaper (9).
An interesting feature of this study is the number 
of infants (19/27) whose CSF tested positive for E4 but 
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Figure 2. Northern part of the Northern Territory of Australia showing 
communities affected by the epidemic febrile vomiting syndrome, 
by week of epidemic peak.
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lacked concomitant pleocytosis. This fi nding may have 
been due to our broad case defi nition and the diligence in 
investigating febrile neonates to exclude bacterial causes. 
The immaturity of the immune system in infants who 
were moderately ill with viremia could also have been a 
factor.
Previously reported outbreaks of enteroviral meningitis 
have demonstrated a predominance of males in childhood 
cases (10–12), and our study’s fi ndings were consistent 
with this. Also consistent with previous reports, a signifi -
cant proportion (30%) of our case-patients were <1 year of 
age; however, ≈25% of the case-patients in our study were 
15–24 years of age, an age group not previously recognized 
to be at risk.
Most of our cases occurred during July through De-
cember, which is late in the dry season of the local sub-
tropical climate. Other reports from regions with temper-
ate climates describe epidemics in the summer and autumn 
(10–14).
The spread of the viral illness across the Top End mir-
rors that reported in Spain in 1991 (14). Late in 2007 and 
early in 2008, spread of the syndrome and enteroviral men-
ingitis into Western Australia and South Australia were re-
ported. Additionally, 116 cases were subsequently labora-
tory confi rmed from Western Australia with all 5′ UTR and 
3 VP1 sequences matching the Northern Territory isolates, 
beginning in the eastern Kimberley region adjacent to the 
northern part of the Northern Territory and then spreading 
throughout most of the state. The E4 strain was detected 
by PCR from the CSF cases of meningitis and from throat 
swabs from EFVS patients in Western Australia.
From VP1 sequences the E4 strain was most closely 
related to a Japanese E4 strain and 2 Chinese E4 strains. 
No further clinical or sequence information is available for 
the Japanese strain, but the Chinese strains were respon-
sible for a large outbreak of viral meningitis in the Yanbian 
prefecture of China in 1996 (2). Little epidemiologic infor-
mation is available for this large outbreak, which affected 
thousands of persons. These authors reported that this out-
break was caused by a new enterovirus isolated from 23 
CSF and feces samples. Our review of the whole genome 
sequence information deposited in GenBank demonstrates 
that the Yanbian strains and this strain are closely related 
and belong to the E4 serotype.
This E4 strain is therefore most closely related to other 
E4 strains from the Western Pacifi c Rim region. We could 
not conclude that this E4 enterovirus evolved from the Jap-
anese or Yanbian viruses. However, this E4 strain could 
have either descended from 1 of these strains or shared a 
common ancestor virus due to their close VP1 genetic relat-
edness compared with other E4 strains. The large outbreaks 
of meningitis caused by both this E4 strain and the Yanbian 
E4 strains suggest a lack of previous immunity in the popu-
lations affected.
We have described an outbreak of human infection 
with E4 enterovirus in Australia. The high attack rate and 
the way in which it spread across the Northern Territory 
and into other states of Australia suggest it may be a newly 
introduced virus to which the local population has had no 
previous exposure. The virus likely has been introduced 
through the northern border where there is considerable 
human movement between the Northern Territory and the 
countries to the north. Our fi ndings demonstrate the clinical 
spectrum of illness and geographic spread of E4 enterovi-
rus infection and add to the knowledge of the molecular 
epidemiology of echoviruses.
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Figure 3. Phylogenetic tree of viral protein (VP) 1 gene sequences 
showing the relationship of the Australian echovirus type 4 virus 
(E4) isolate, AUS250G, to E4 strains, 2 Yanbian strains, and an 
echovirus type 1 sequence. The tree was constructed in MEGA 
version 3.0 software (www.megasoftware.net) using the neighbor-
joining method with the Kimura 2-parameter model and 1,000 
bootstrap replicates. Branch numbers represent bootstrap % 
values. Scale bar represents nucleotide substitutions per site.  
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